Peripheral Arterial Disease Trial, Recruiting NCT06434194 Sponsor: Cagent Vascular LLC Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT06434194
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People whose affected leg has been classified as Rutherford category 4, 5, or 6, which generally means serious limb problems such as rest pain, minor tissue loss, or major tissue loss (confirm with trial site)
  • People who are older than 18 years of age
  • People who have agreed to take part by signing an informed consent form

Who may not be able to join:

  • People whose target blood vessel blockage or narrowing is either a new blockage or a re-narrowing that has not previously had a stent placed in it, and where the narrowing is 70% or more, or where the vessel is fully blocked
  • People whose affected blood vessel is located below the knee, including specific vessels in the lower leg and foot (such as the below-knee popliteal artery, tibioperoneal trunk, tibial, peroneal, or pedal arteries)
  • People whose affected blood vessel has a diameter that falls between 2.0 and 5.0 mm as estimated during imaging (confirm with trial site)
  • People whose affected vessel blockage or narrowing is shorter than 220 mm in length

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 4197878496

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Cagent Vascular LLC
Registry
ClinicalTrials.gov
Start date
31 October 2024
Est. completion
1 June 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Residual Lumen Volume Stenosis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov